EverydayHealthLogo
Dr. Charles Prober, MD

Dr. Charles Prober, MD

Palo Alto, CA

46 Years of Experience

Accepting patients

    Who is Dr. Prober, Pediatric Infectious Diseases Specialist in Palo Alto, CA?

    Dr. Charles Prober, MD is a Pediatric Infectious Diseases Specialist, who primarily practices in Palo Alto, CA. He has been practicing for over 46 years and is board certified. Dr. Prober completed his residency at Calif-Moffitt Hosp. Dr. Prober is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Prober’s office at (650) 497-8000.

    Where did Dr. Prober go to medical school and complete their residency?

    • Fellowship: Stanford University School of Medicine, Stanford, CA | Stanford University School of Medicine CA

    • Residency: Calif-Moffitt Hosp | Children's Hospital, Winnipeg, Canada | University of California, San Francisco | Children's Hospital, Canada | University of Manitoba Affiliated Hospitals

    • Medical School: University of Manitoba Fac of Medicine

    Is Dr. Prober board certified as a Pediatric Infectious Diseases Specialist?

    Yes, Dr. Charles Prober, MD is board certified by the American Board of Pediatrics , American Board of Pediatrics since 1978

    What languages does Dr. Prober speak?

    Dr. Prober and their clinical team can communicate with patients in the following languages:

    • English
    • Spanish

    What conditions does a Pediatric Infectious Diseases Specialist like Dr. Prober typically treat?

    What procedures does a Pediatric Infectious Diseases Specialist like Dr. Prober typically perform?

    As a Pediatric Infectious Diseases Specialist, procedures performed by Dr. Charles Prober may include:

    Please contact Dr. Prober's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Prober accept my insurance?

    Please contact Dr. Prober's office to confirm accepted insurance plans.

    Where is Dr. Prober's office located?

    Dr. Charles Prober's Primary Practice

    725 Welch Rd

    Palo Alto, CA 94304

    (650) 497-8000

    Get Directions

    What hospitals are Dr. Prober affiliated with?

    Dr. Prober has admitting privileges at the following hospitals:

    Stanford Medicine Children’s Health,Palo Alto, CA

    Recognitions

    Awards

    • Henry J. Kaiser Award for Preclinical Teaching, Stanford University Sc, 1994

    • The Harry Bain Award for Excellence in Clinical Teaching, The Hospita, 1984

    • Mayne Guest Professorship, Department of Child Health,, 1989

    • National Institutes of Health, Immunologic and Infectious Diseases Ac

    • Arthur L. Bloomfield Award for Teaching of Clinical Medicine, Stanfor, 1989

    • Henry J. Kaiser Award for Clinical Teaching, Stanford University Scho, 1990

    Publications

    • Lecture halls without lectures--a proposal for medical education., 2012

    • Decisions, Decisions: How Program Diversity Influences Residency Program Choice, 2011

    • Commentary: To Genotype or Not to Genotype? Addressing the Debate Through the Development of a, 2011

    • Human Herpesvirus 6, 2011

    • Principles & Practice of Pediatric Infectious Diseases

    • Treatment of turally acquired common colds with zinc: A structured review, 2007

    • Effect of materl herpes simplex virus (HSV) serostatus and HSV type on risk of neotal herpes, 2007

    • Materl herpes simplex virus antibody avidity and risk of neotal herpes, 2006

    • Sixth disease and the ubiquity of human herpesviruses, 2005

    • Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, 2004

    • New antivirals and antiviral resistance, 2004

    • Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections., 2003

    • Congenital cytomegalovirus (CMV) infections: Hats off to Alabama, 2003

    • Neotal herpes infection: diagnosis, treatment and prevention., 2002

    • Antiviral therapy for influenza virus infections., 2002

    • Prevention of hepatitis B in adolescents, 2001

    • Pediatric uses of valacyclovir, penciclovir and famciclovir, 2001

    • Antiviral agents effective against herpesviruses., 2001

    • Magement of the neote whose mother received suppressive acyclovir therapy during late pregncy, 2001

    • Technical report: precautions regarding the use of aerosolized antibiotics. Committee on Infectious, 2000

    • Advances in prevention of respiratory syncytial virus infections, 1999

    • Possible association of intussusception with rotavirus vaccition. American Academy of Pediatrics., 1999

    • Posttraumatic invasive Aspergillus fumigatus wound infection, 1999

    • Cephalosporins: an update., 1998

    • Encephalitis - Identifying the specific cause is key to effective magement, 1998

    • Acyclovir therapy in a steroid recipient with varicella, 1997

    • Herpes simplex virus type 2 - A persistent problem, 1997

    • Genital herpes during pregncy: Ibility to distinguish primary and recurrent infections clinically, 1997

    • Bacterial resistance and the dilemma of antibiotic usage, 1997

    • Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus, 1997

    • Application of the polymerase chain reaction to the diagnosis, 1996

    • T cell recognition and cytokine production elicited by common and type, 1996

    • Antibiotic update: Overview, 1996

    • Pharmacokinetic optimisation of the treatment of septic arthritis, 1996

    • Epidemiology of herpes simplex virus type 2 infections in a high-risk adolescent population, 1996

    • Pediatric resident training in a school environment - A prescription for learning, 1996

    • Early diagnosis and magement of herpes simplex encephalitis, 1996

    • Herpesvirus infections of the vulva, 1996

    • THE ROLE OF STEROIDS IN THE MAGEMENT OF CHILDREN WITH BACTERIAL-MENINGITIS, 1995

    • ALYSIS OF THE EPIDEMIOLOGY AND PATHOGENESIS OF HERPES-SIMPLEX VIRUS, 1993

    • CESAREAN DELIVERY FOR WOMEN PRESENTING WITH GENITAL HERPES LESIONS - EFFICACY, RISKS, AND COSTS, 1993

    • FEVER AND INFECTION IN THE AGE SINCE WUNDERLICH, 1993

    • HERPETIC VAGINITIS IN 1993, 1993

    • Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing, 1993

    • Neotal herpes: vexing dilemmas and reasons for hope., 1993

    • THE MAGEMENT OF PREGNCIES COMPLICATED BY GENITAL INFECTIONS WITH HERPES-SIMPLEX VIRUS, 1992

    • IDENTIFICATION OF WOMEN AT UNSUSPECTED RISK OF PRIMARY INFECTION WITH HERPES-SIMPLEX VIRUS TYPE, 1992

    • RESPIRATORY SYNCYTIAL VIRUS AND RIBAVIRIN - QUO-VADIS, 1992

    • Acyclovir treatment of varicella, 1992

    • PROPHYLACTIC FLUCOZOLE AND CANDIDA-KRUSEI INFECTIONS, 1992

    • Herpes simplex virus infections: the genital tract and the newborn., 1992

    • CURRENT ANTIBIOTIC-THERAPY OF COMMUNITY, 1992

    • POTENTIAL OF POPULATION PHARMACOKINETICS TO REDUCE THE FREQUENCY OF BLOOD, 1992

    • Investigation of varicella, 1992

    • MEDICAL-MAGEMENT OF NEWBORNS AND INFANTS BORN TO HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE MOTHERS, 1991

    • A CONTROLLED TRIAL OF AEROSOLIZED RIBAVIRIN IN INFANTS RECEIVING MECHANICAL VENTILATION, 1991

    • THE IMPACT OF RESPIRATORY VIRAL-INFECTIONS IN PATIENTS WITH CYSTIC-FIBROSIS, 1991

    • PREDICTORS OF MORBIDITY AND MORTALITY IN NEOTES WITH HERPES-SIMPLEX VIRUS-INFECTIONS, 1991

    • A CONTROLLED TRIAL COMPARING VIDARABINE WITH ACYCLOVIR IN NEOTAL HERPES-SIMPLEX VIRUS-INFECTION, 1991

    • PHARMACOKINETICS OF ACYCLOVIR IN THE TERM HUMAN-PREGNCY AND NEOTE, 1991

    • CRYPTOCOCCUS INFECTION IN A 9-YEAR, 1991

    • THE RISK OF DEXAMETHASONE IN PREGNT-WOMEN WITH A HISTORY OF RECURRENT GENITAL HERPES, 1991

    • CONSENSUS - VARICELLA-ZOSTER INFECTIONS IN PREGNCY AND THE PERITAL-PERIOD, 1990

    • USE OF POLYMERASE CHAIN-REACTION FOR SUCCESSFUL IDENTIFICATION OF ASYMPTOMATIC GENITAL, 1990

    • HERPES-SIMPLEX VIRUS-INFECTIONS, 1990

    • GENTAMICIN PHARMACOKINETICS IN NEOTES UNDERGOING EXTRACORPOREAL MEMBRANE-OXYGETION, 1990

    • A PROSPECTIVE EVALUATION OF PRIMARY GENITAL HERPES-SIMPLEX VIRUS TYPE, 1990

    • THE USE OF ANTIBIOTICS IN NEOTES WEIGHING LESS THAN 1200 GRAMS, 1990

    • NEOTAL ANTIBODY-DEPENDENT CELLULAR CYTO, 1989

    • VANCOMYCIN PHARMACOKINETICS IN VERY LOW BIRTH-WEIGHT NEOTES, 1989

    • Genital herpes and the pregnt woman., 1989

    • PHARMACOKINETICS AND ADVERSE-EFFECTS OF AMPHOTERICIN-B IN INFANTS AND CHILDREN, 1988

    • USE OF ROUTINE VIRAL CULTURES AT DELIVERY TO IDENTIFY NEOTES EXPOSED TO HERPES-SIMPLEX VIRUS, 1988

    • TYPE-SPECIFIC ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) GLYCOPROTEIN-G IN PREGNT-WOMEN, 1988

    • RECURRENT URETHRITIS ASSOCIATED WITH UREAPLASMA-UREALYTICUM IN A PREPUBERTAL BOY, 1987

    • PERITAL VIRAL-INFECTIONS, 1987

    • FALSE POSITIVITY OF LEGIONELLA SEROLOGY IN PATIENTS WITH CYSTIC-FIBROSIS, 1987

    • LOW-RISK OF HERPES-SIMPLEX VIRUS-INFECTIONS IN NEOTES EXPOSED TO THE VIRUS AT THE TIME OF VAGIL, 1987

    • VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS, 1987

    • FAILURE OF ANTEPARTUM MATERL CULTURES TO PREDICT THE INFANTS RISK OF EXPOSURE TO HERPES, 1986

    • RIFAMPIN ALONE OR WITH TRIMETHOPRIM FOR CONTACTS OF CHILDREN WITH HAEMOPHILUS-INFLUENZAE TYPE, 1986

    • SEQUELAE OF ACUTE BACTERIAL-MENINGITIS IN CHILDREN TREATED FOR 7 DAYS, 1986

    • THE VALUE OF SKIN BIOPSIES IN FEBRILE, NEUTROPENIC, IMMUNOCOMPROMISED CHILDREN, 1986

    • PRIMARY OSTEOMYELITIS CAUSED BY COAGULASE-NEGATIVE STAPHYLOCOCCI, 1986

    • AN UNUSUAL CASE OF INTRACRANIAL SUPPURATION, 1985

    • DACTYLITIS IN A CHILD WITH SICKLE-CELL TRAIT, 1985

    • EFFECT OF RIFAMPIN ON CHLORAMPHENICOL LEVELS, 1985

    • BRAIN ABSCESSES IN INFANTS AND CHILDREN, 1985

    • PERSISTENT FEVER AND SUBDURAL EFFUSIONS, 1985

    • TREATMENT OF BACTERIAL-INFECTIONS IN THE NEOTE, 1985

    • INVITRO INTERACTIONS BETWEEN RIFAMPIN AND AMPICILLIN OR CHLORAMPHENICOL AGAINST HEMOPHILUS, 1984

    • AMINOGLYCOSIDE-RELATED NEPHROTOXICITY IN THE PREMATURE NEWBORN, 1984

    • ASSOCIATION OF RESPIRATORY VIRAL-INFECTIONS WITH PULMORY DETERIORATION IN PATIENTS WITH CYSTIC, 1984

    • SYSTEMIC TINEA VERSICOLOR, OR HOW FAR CAN FURFUR GO, 1984

    • PROPHYLACTIC SULFAMETHOXAZOLE AND TRIMETHOPRIM IN VENTRICULOPERITONEAL SHUNT SURGERY - A DOUBLE, 1984

    • SPUTUM BACTERIOLOGY IN PATIENTS WITH CYSTIC-FIBROSIS IN A TORONTO HOSPITAL DURING 1970-1981, 1984

    • THE MAGEMENT OF CENTRAL INTRAVENOUS CATHETER INFECTIONS, 1984

    • OPEN LUNG-BIOPSY IN IMMUNOCOMPROMISED CHILDREN WITH PULMORY-INFILTRATES, 1984

    • PSEUDOMOS CEPACIA INFECTION IN CYSTIC-FIBROSIS - AN EMERGING PROBLEM, 1984

    • AMIKACIN DOSES IN VERY LOW-BIRTH-WEIGHT NEWBORNS, 1983

    • TOWARD OPTIMIZATION OF THERAPY IN THE NEOTE, 1983

    • THE HIGH-PERFORMANCE LIQUID, 1983

    • IMPACT OF CHLORAMPHENICOL USE ON BACTERIAL-RESISTANCE IN A NEOTAL INTENSIVE-CARE UNIT, 1983

    • CEFOPERAZONE - A COMPARATIVE INVITRO CADIAN STUDY OF 1743 PATHOGENS, 1983

    • MEASUREMENT OF AMPHOTERICIN-B IN SERUM OR PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, 1983

    • Chloramphenicol in the newborn infant., 1983

    • VENTRICULAR CEREBROSPIL-FLUID CONCENTRATIONS OF TRIMETHOPRIM-SULFAMETHOXAZOLE, 1983

    • CHLORAMPHENICOL PHARMACOKINETICS IN THE NEWBORN, 1983

    • VARICELLA ZOSTER VIRUS, 1983

    • IMMUNOLOGICAL RESPONSES OF CHILDREN TO SERIOUS INFECTIONS WITH STREPTOCOCCUS-PNEUMONIAE, 1983

    • FEVER IN A NEWBORN, 1982

    • HEMOPHILUS-INFLUENZAE TYPE-B IN A NURSERY-SCHOOL - THE VALUE OF BIOTYPING, 1982

    • ORAL ANTIBIOTIC-THERAPY FOR BONE AND JOINT INFECTIONS, 1982

    • ACYCLOVIR THERAPY OF CHICKENPOX IN IMMUNOSUPPRESSED CHILDREN - A COLLABORATIVE STUDY, 1982

    • INITIATION OF CHLORAMPHENICOL THERAPY IN THE NEWBORN-INFANT, 1982

    • PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALO-VIRUS INFECTIONS IN NEWBORN-INFANTS, 1981

    • SIDE-EFFECTS OF CLOXACILLIN IN INFANTS AND CHILDREN, 1981

    • EIKENELLA-CORRODENS EMPYEMA IN CHILDREN, 1981

    • THE EFFECT OF CHRONOLOGIC AGE ON THE SERUM CONCENTRATIONS OF AMIKACIN IN SICK TERM AND PREMATURE, 1981

    • Antibiotic abuse: spare the child., 1980

    • COMPARISON OF A MICROMETHOD FOR PERFORMANCE OF THE SERUM BACTERICIDAL TEST WITH THE STANDARD TUBE, 1979

    • USE OF THE SERUM BACTERICIDAL TITER TO ASSESS THE ADEQUACY OF ORAL ANTIBIOTIC, 1979

    • WHITE CELL RATIO IN THE VERY LOW BIRTH-WEIGHT INFANT, 1979

    • STORAGE AND TRANSPORT OF CULTURES FOR HERPES-SIMPLEX VIRUS, TYPE-2, 1979

    • YERSINIA-PSEUDOTUBERCULOSIS SEPTICEMIA, 1979

    What is Dr. Prober's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Prober's National Provider Identifier (NPI) number is 1447385711.

    What common questions do patients ask about Dr. Prober?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Prober

    What is Dr. Charles Prober's specialty?

    What does a Pediatric Infectious Diseases Specialist do?

    A pediatrician trained in the diagnosis, treatment, and prevention of infectious diseases in children. This specialist utilizes their expertise to improve outcomes for pediatric infections, particularly those with complicated courses, underlying conditions that increase the risk of unusual or severe infections, ambiguous diagnoses, rare diseases, and complex or investigational treatments.

    Is Dr. Charles Prober affiliated with a ranked Castle Connolly Top Hospital?

    No, Dr. Prober is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see a Pediatric Infectious Diseases Specialist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see a Pediatric Infectious Diseases Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Dr. Charles Prober accepting new patients in Palo Alto, CA?

    Yes, Dr. Charles Prober is accepting new patients at this time.

    Does Dr. Charles Prober offer online booking?

    Please contact Dr. Prober's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Dr. Charles Prober?

    Please contact Dr. Prober's office at (650) 497-8000 to schedule an appointment.

    Where is Dr. Prober's office located?

    Dr. Prober's office is located in Palo Alto, CA.

    Which board certifications does Dr. Charles Prober have?

    Dr. Charles Prober is certified by the American Board of Pediatrics.